img

Global Pulmonary Embolism Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pulmonary Embolism Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Pulmonary Embolism Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pulmonary Embolism Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pulmonary Embolism Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pulmonary Embolism Drug key manufacturers include Accu-Break Pharmaceuticals, Inc., Dong-A Socio Holdings Co. Ltd., F. Hoffmann-La Roche Ltd., Genentech, Inc. and Verseon Corp, etc. Accu-Break Pharmaceuticals, Inc., Dong-A Socio Holdings Co. Ltd., F. Hoffmann-La Roche Ltd. are top 3 players and held % sales share in total in 2022.
Pulmonary Embolism Drug can be divided into DS-9231, DS-1040, TRX-1 and Others, etc. DS-9231 is the mainstream product in the market, accounting for % sales share globally in 2022.
Pulmonary Embolism Drug is widely used in various fields, such as Hospital, Clinic and Others,, etc. Hospital provides greatest supports to the Pulmonary Embolism Drug industry development. In 2022, global % sales of Pulmonary Embolism Drug went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pulmonary Embolism Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Accu-Break Pharmaceuticals, Inc.
Dong-A Socio Holdings Co. Ltd.
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Verseon Corp
Segment by Type
DS-9231
DS-1040
TRX-1
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pulmonary Embolism Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pulmonary Embolism Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pulmonary Embolism Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pulmonary Embolism Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pulmonary Embolism Drug introduction, etc. Pulmonary Embolism Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pulmonary Embolism Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Pulmonary Embolism Drug Market Overview
1.1 Pulmonary Embolism Drug Product Overview
1.2 Pulmonary Embolism Drug Market Segment by Type
1.2.1 DS-9231
1.2.2 DS-1040
1.2.3 TRX-1
1.2.4 Others
1.3 Global Pulmonary Embolism Drug Market Size by Type
1.3.1 Global Pulmonary Embolism Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Pulmonary Embolism Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Pulmonary Embolism Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pulmonary Embolism Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Pulmonary Embolism Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Pulmonary Embolism Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Pulmonary Embolism Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Pulmonary Embolism Drug Sales Breakdown by Type (2018-2024)
2 Global Pulmonary Embolism Drug Market Competition by Company
2.1 Global Top Players by Pulmonary Embolism Drug Sales (2018-2024)
2.2 Global Top Players by Pulmonary Embolism Drug Revenue (2018-2024)
2.3 Global Top Players by Pulmonary Embolism Drug Price (2018-2024)
2.4 Global Top Manufacturers Pulmonary Embolism Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pulmonary Embolism Drug Market Competitive Situation and Trends
2.5.1 Pulmonary Embolism Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pulmonary Embolism Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pulmonary Embolism Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Pulmonary Embolism Drug Market
2.8 Key Manufacturers Pulmonary Embolism Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pulmonary Embolism Drug Status and Outlook by Region
3.1 Global Pulmonary Embolism Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Pulmonary Embolism Drug Historic Market Size by Region
3.2.1 Global Pulmonary Embolism Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Pulmonary Embolism Drug Sales in Value by Region (2018-2024)
3.2.3 Global Pulmonary Embolism Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Pulmonary Embolism Drug Forecasted Market Size by Region
3.3.1 Global Pulmonary Embolism Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Pulmonary Embolism Drug Sales in Value by Region (2024-2034)
3.3.3 Global Pulmonary Embolism Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Pulmonary Embolism Drug by Application
4.1 Pulmonary Embolism Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Pulmonary Embolism Drug Market Size by Application
4.2.1 Global Pulmonary Embolism Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Pulmonary Embolism Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Pulmonary Embolism Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pulmonary Embolism Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Pulmonary Embolism Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Pulmonary Embolism Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Pulmonary Embolism Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Pulmonary Embolism Drug Sales Breakdown by Application (2018-2024)
5 North America Pulmonary Embolism Drug by Country
5.1 North America Pulmonary Embolism Drug Historic Market Size by Country
5.1.1 North America Pulmonary Embolism Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Pulmonary Embolism Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Pulmonary Embolism Drug Sales in Value by Country (2018-2024)
5.2 North America Pulmonary Embolism Drug Forecasted Market Size by Country
5.2.1 North America Pulmonary Embolism Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Pulmonary Embolism Drug Sales in Value by Country (2024-2034)
6 Europe Pulmonary Embolism Drug by Country
6.1 Europe Pulmonary Embolism Drug Historic Market Size by Country
6.1.1 Europe Pulmonary Embolism Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Pulmonary Embolism Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Pulmonary Embolism Drug Sales in Value by Country (2018-2024)
6.2 Europe Pulmonary Embolism Drug Forecasted Market Size by Country
6.2.1 Europe Pulmonary Embolism Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Pulmonary Embolism Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Pulmonary Embolism Drug by Region
7.1 Asia-Pacific Pulmonary Embolism Drug Historic Market Size by Region
7.1.1 Asia-Pacific Pulmonary Embolism Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Pulmonary Embolism Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Pulmonary Embolism Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Pulmonary Embolism Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Pulmonary Embolism Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Pulmonary Embolism Drug Sales in Value by Region (2024-2034)
8 Latin America Pulmonary Embolism Drug by Country
8.1 Latin America Pulmonary Embolism Drug Historic Market Size by Country
8.1.1 Latin America Pulmonary Embolism Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Pulmonary Embolism Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Pulmonary Embolism Drug Sales in Value by Country (2018-2024)
8.2 Latin America Pulmonary Embolism Drug Forecasted Market Size by Country
8.2.1 Latin America Pulmonary Embolism Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Pulmonary Embolism Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Pulmonary Embolism Drug by Country
9.1 Middle East and Africa Pulmonary Embolism Drug Historic Market Size by Country
9.1.1 Middle East and Africa Pulmonary Embolism Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Pulmonary Embolism Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Pulmonary Embolism Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Pulmonary Embolism Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Pulmonary Embolism Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Pulmonary Embolism Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Accu-Break Pharmaceuticals, Inc.
10.1.1 Accu-Break Pharmaceuticals, Inc. Company Information
10.1.2 Accu-Break Pharmaceuticals, Inc. Introduction and Business Overview
10.1.3 Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Products Offered
10.1.5 Accu-Break Pharmaceuticals, Inc. Recent Development
10.2 Dong-A Socio Holdings Co. Ltd.
10.2.1 Dong-A Socio Holdings Co. Ltd. Company Information
10.2.2 Dong-A Socio Holdings Co. Ltd. Introduction and Business Overview
10.2.3 Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Products Offered
10.2.5 Dong-A Socio Holdings Co. Ltd. Recent Development
10.3 F. Hoffmann-La Roche Ltd.
10.3.1 F. Hoffmann-La Roche Ltd. Company Information
10.3.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.3.3 F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Products Offered
10.3.5 F. Hoffmann-La Roche Ltd. Recent Development
10.4 Genentech, Inc.
10.4.1 Genentech, Inc. Company Information
10.4.2 Genentech, Inc. Introduction and Business Overview
10.4.3 Genentech, Inc. Pulmonary Embolism Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Genentech, Inc. Pulmonary Embolism Drug Products Offered
10.4.5 Genentech, Inc. Recent Development
10.5 Verseon Corp
10.5.1 Verseon Corp Company Information
10.5.2 Verseon Corp Introduction and Business Overview
10.5.3 Verseon Corp Pulmonary Embolism Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Verseon Corp Pulmonary Embolism Drug Products Offered
10.5.5 Verseon Corp Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pulmonary Embolism Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pulmonary Embolism Drug Industrial Chain Analysis
11.4 Pulmonary Embolism Drug Market Dynamics
11.4.1 Pulmonary Embolism Drug Industry Trends
11.4.2 Pulmonary Embolism Drug Market Drivers
11.4.3 Pulmonary Embolism Drug Market Challenges
11.4.4 Pulmonary Embolism Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pulmonary Embolism Drug Distributors
12.3 Pulmonary Embolism Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of DS-9231
Table 2. Major Company of DS-1040
Table 3. Major Company of TRX-1
Table 4. Major Company of Others
Table 5. Global Pulmonary Embolism Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Pulmonary Embolism Drug Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Pulmonary Embolism Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Pulmonary Embolism Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Pulmonary Embolism Drug Market Share in Value by Type (2018-2024)
Table 10. Global Pulmonary Embolism Drug Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Pulmonary Embolism Drug Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Pulmonary Embolism Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Pulmonary Embolism Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Pulmonary Embolism Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Pulmonary Embolism Drug Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Pulmonary Embolism Drug Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Pulmonary Embolism Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Pulmonary Embolism Drug Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Pulmonary Embolism Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Pulmonary Embolism Drug Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Pulmonary Embolism Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Pulmonary Embolism Drug Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Pulmonary Embolism Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Pulmonary Embolism Drug Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Pulmonary Embolism Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Pulmonary Embolism Drug Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Pulmonary Embolism Drug Sales Share by Company (2018-2024)
Table 28. Global Pulmonary Embolism Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Pulmonary Embolism Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Pulmonary Embolism Drug Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Pulmonary Embolism Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Pulmonary Embolism Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pulmonary Embolism Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Pulmonary Embolism Drug Market
Table 35. Key Manufacturers Pulmonary Embolism Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Pulmonary Embolism Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Pulmonary Embolism Drug Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Pulmonary Embolism Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Pulmonary Embolism Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Pulmonary Embolism Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Pulmonary Embolism Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Pulmonary Embolism Drug Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Pulmonary Embolism Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Pulmonary Embolism Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Pulmonary Embolism Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Pulmonary Embolism Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Pulmonary Embolism Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Pulmonary Embolism Drug Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Pulmonary Embolism Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Pulmonary Embolism Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Pulmonary Embolism Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Pulmonary Embolism Drug Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Pulmonary Embolism Drug Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Pulmonary Embolism Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Pulmonary Embolism Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Pulmonary Embolism Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Pulmonary Embolism Drug Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Pulmonary Embolism Drug Sales by Application (2018-2024) (K Pcs)
Table 60. North America Pulmonary Embolism Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Pulmonary Embolism Drug Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Pulmonary Embolism Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Pulmonary Embolism Drug Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Pulmonary Embolism Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Pulmonary Embolism Drug Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Pulmonary Embolism Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Pulmonary Embolism Drug Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Pulmonary Embolism Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Pulmonary Embolism Drug Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Pulmonary Embolism Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Pulmonary Embolism Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Pulmonary Embolism Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Pulmonary Embolism Drug Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Pulmonary Embolism Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Pulmonary Embolism Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Pulmonary Embolism Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Pulmonary Embolism Drug Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Pulmonary Embolism Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Pulmonary Embolism Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Pulmonary Embolism Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Pulmonary Embolism Drug Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Pulmonary Embolism Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Pulmonary Embolism Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Pulmonary Embolism Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Pulmonary Embolism Drug Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Pulmonary Embolism Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Pulmonary Embolism Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Pulmonary Embolism Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Pulmonary Embolism Drug Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Pulmonary Embolism Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Pulmonary Embolism Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Pulmonary Embolism Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Pulmonary Embolism Drug Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Pulmonary Embolism Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Pulmonary Embolism Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Pulmonary Embolism Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Pulmonary Embolism Drug Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Pulmonary Embolism Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Pulmonary Embolism Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Pulmonary Embolism Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Pulmonary Embolism Drug Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Pulmonary Embolism Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Pulmonary Embolism Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Pulmonary Embolism Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Pulmonary Embolism Drug Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Pulmonary Embolism Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Pulmonary Embolism Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Pulmonary Embolism Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Accu-Break Pharmaceuticals, Inc. Company Information
Table 110. Accu-Break Pharmaceuticals, Inc. Introduction and Business Overview
Table 111. Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Accu-Break Pharmaceuticals, Inc. Pulmonary Embolism Drug Product
Table 113. Accu-Break Pharmaceuticals, Inc. Recent Development
Table 114. Dong-A Socio Holdings Co. Ltd. Company Information
Table 115. Dong-A Socio Holdings Co. Ltd. Introduction and Business Overview
Table 116. Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. Dong-A Socio Holdings Co. Ltd. Pulmonary Embolism Drug Product
Table 118. Dong-A Socio Holdings Co. Ltd. Recent Development
Table 119. F. Hoffmann-La Roche Ltd. Company Information
Table 120. F. Hoffmann-La Roche Ltd. Introduction and Business Overview
Table 121. F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. F. Hoffmann-La Roche Ltd. Pulmonary Embolism Drug Product
Table 123. F. Hoffmann-La Roche Ltd. Recent Development
Table 124. Genentech, Inc. Company Information
Table 125. Genentech, Inc. Introduction and Business Overview
Table 126. Genentech, Inc. Pulmonary Embolism Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. Genentech, Inc. Pulmonary Embolism Drug Product
Table 128. Genentech, Inc. Recent Development
Table 129. Verseon Corp Company Information
Table 130. Verseon Corp Introduction and Business Overview
Table 131. Verseon Corp Pulmonary Embolism Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Verseon Corp Pulmonary Embolism Drug Product
Table 133. Verseon Corp Recent Development
Table 134. Key Raw Materials Lists
Table 135. Raw Materials Key Suppliers Lists
Table 136. Pulmonary Embolism Drug Market Trends
Table 137. Pulmonary Embolism Drug Market Drivers
Table 138. Pulmonary Embolism Drug Market Challenges
Table 139. Pulmonary Embolism Drug Market Restraints
Table 140. Pulmonary Embolism Drug Distributors List
Table 141. Pulmonary Embolism Drug Downstream Customers
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Embolism Drug Product Picture
Figure 2. Global Pulmonary Embolism Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pulmonary Embolism Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Pulmonary Embolism Drug Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of DS-9231
Figure 6. Global DS-9231 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of DS-1040
Figure 8. Global DS-1040 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of TRX-1
Figure 10. Global TRX-1 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Pulmonary Embolism Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Pulmonary Embolism Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Pulmonary Embolism Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Pulmonary Embolism Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Pulmonary Embolism Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Pulmonary Embolism Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Pulmonary Embolism Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Pulmonary Embolism Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Pulmonary Embolism Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Pulmonary Embolism Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Pulmonary Embolism Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Pulmonary Embolism Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Pulmonary Embolism Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Pulmonary Embolism Drug Revenue in 2022
Figure 27. Pulmonary Embolism Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Global Pulmonary Embolism Drug Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Pulmonary Embolism Drug Sales Market Share by Application in 2022 & 2034
Figure 36. North America Pulmonary Embolism Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Pulmonary Embolism Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Pulmonary Embolism Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Pulmonary Embolism Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Pulmonary Embolism Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Pulmonary Embolism Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Pulmonary Embolism Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Pulmonary Embolism Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Pulmonary Embolism Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Pulmonary Embolism Drug Manufacturing Cost Structure
Figure 47. Pulmonary Embolism Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries